Guides

Prostate cancer PSA screening: ACS sets age-based testing plan

14 Nov 2026

The ACS now recommends prostate cancer PSA screening every two years for average-risk men 50–69, with earlier or yearly testing for some higher-risk men.

Prostate cancer PSA screening: ACS sets age-based testing plan

The American Cancer Society’s prostate cancer PSA screening plan calls for testing every two years for average-risk men ages 50 to 69, with earlier and more frequent screening for some higher-risk men.

Key takeaways

  • The prostate cancer PSA screening plan recommends testing every two years for average-risk men ages 50 to 69.
  • Black men are advised to start annual testing at 45, while some non-Black men with specified family histories are also advised to begin at 45.
  • For non-Black men with one close relative diagnosed at 65 or older, the reported schedule is a PSA test every two years beginning at 45.
  • The prostate cancer PSA screening plan recommends biennial tests for average-risk men ages 50 to 69.
  • Black men and some men with a family history are advised to begin annual screening at age 45.
  • The American Cancer Society’s new guidance marks a shift toward routine testing, but the supplied report does not explain how screening decisions should be discussed with a clinician.

What changed

The American Cancer Society (ACS) now recommends routine prostate cancer screening with a PSA, or prostate-specific antigen, blood test. Its updated guidance sets different starting ages and testing intervals according to a man’s risk factors.

For men at average risk, the ACS recommends a PSA test every two years from age 50 through 69. The recommendation is not for annual testing across this group; the interval is two years.

The guidance calls for earlier, yearly screening for Black men, beginning at age 45. The ACS bases this distinction on the higher rates of prostate cancer among Black men, as described in the supplied Ars Technica report.

Family history also affects the schedule for non-Black men. The report says yearly testing from age 45 is recommended if a close relative developed prostate cancer before age 65, or if more than one relative has had the disease.

A separate family-history case has a less frequent interval: non-Black men with one close relative diagnosed at age 65 or older should begin at 45, but get tested every two years. The recommendations therefore distinguish both the number of affected relatives and the age at diagnosis.

Why it matters

Analysis: Screening advice can shape when people seek a test and how often they return for it. The ACS guidance gives readers a clearer age-and-risk framework than a single schedule for everyone, while recognizing that family history and race affect the recommendations presented in the report.

The change matters most to men approaching the stated starting ages, as well as people whose close relatives have had prostate cancer. Under the new guidance, two people the same age may be directed toward different testing intervals because their risk categories differ.

It also makes the PSA test itself a more routine part of the ACS’s screening advice. The source does not provide details about possible benefits, harms, or how patients should weigh them, so those questions cannot be answered from this report alone.

The TechnoRapper editorial desk used the supplied Ars Technica report as its factual source and reorganized the recommendations around the decisions readers need to understand. No additional clinical guidance or independent reporting has been added.

Who is affected

Men aged 50 to 69 who are considered average risk fall under the every-two-years recommendation. The reported guidance does not specify a routine schedule beyond that age range for this group.

Black men are advised to start at 45 and test yearly. This recommendation applies to all Black men in the supplied account, rather than only those with a known family history.

Non-Black men with a close relative diagnosed before 65, or with multiple relatives who have had prostate cancer, are also advised to start at 45 and screen annually. If one close relative was diagnosed at 65 or older, the starting age remains 45, but the interval changes to every two years.

These categories make the details of family history relevant: whether a relative had prostate cancer, how many relatives were affected, and how old the relative was at diagnosis. The source does not define “close relative” more precisely, so readers should not infer a specific list of relatives from this account.

What to watch next

Readers should watch for how the updated ACS recommendations are presented in clinical settings and whether additional guidance clarifies how people should apply the risk categories. The supplied report says the guidelines were released Thursday, but does not provide further implementation details.

For anyone trying to identify the relevant interval, the key distinctions in the source are age, race, number of affected relatives, and a relative’s age at diagnosis. The report does not say what testing schedule applies to people whose circumstances do not fit one of the described groups.

It is also important to keep the limits of this account in view: it reports who the ACS recommends screening and when, but does not explain what a PSA result means or outline follow-up steps. Those topics remain unresolved by the supplied material.

Frequently asked questions

When should average-risk men start prostate cancer PSA screening?
The ACS recommends that average-risk men begin PSA testing at age 50 and continue every two years through age 69. The supplied report does not state a routine schedule for this group after 69.

Which men are advised to start PSA screening at 45?
The guidance recommends starting at 45 for all Black men. It also sets age 45 as the starting point for non-Black men with specified family histories, although their recommended testing interval depends on those details.

How often should men with a family history get tested?
Non-Black men with a close relative diagnosed before 65, or more than one relative who has had prostate cancer, are advised to test yearly from age 45. If one close relative was diagnosed at 65 or older, the reported recommendation is testing every two years starting at 45.

Related on TechnoRapper

Inspired by: Ars Technica

How we used the source: facts, quotes, and numbers in this article come only from that Inspired by link. We added structure, search intent, and reader context. We did not independently verify the reporting.